Cognition Therapeutics received grant support from the NIH segment on July 12, 2025, for a clinical study.
2 reports, 1 independent
Updated Jul 12
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Cognition Therapeutics received grant support from the NIH segment on July 12, 2025, for a clinical study.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Cognition Therapeutics (United States)
company in Pittsburgh, United States
Nothing else this week.
-
National Institutes of Health
government organization in Shah Alam, Malaysia
Related events
- NIH provided federal grant funding to UF for research.
- The National Institutes of Health awarded funds to the University of Illinois Urbana-Champaign for research.
- NIH, NSF, and CEPI provided research grants and investment to university faculty on August 4, 2026.
- The Office of Management and Budget proposes changes to federal funding policies affecting the National Institutes of Health.
- The Trump administration seeks greater control over NIH grantmaking, while Susan Collins objects to the Office of Management and Budget's involvement.
Coverage
Newest first; wire copies grouped- Insider MonkeyCognition Therapeutics, Inc. (CGTX) Retains Buy Rating on START Study Progress Cognition Therapeutics, Inc. (NASDAQ:CGTX) is among the fundamentally strong penny stocks to invest in. H.C. Wainwright
- Unknown outlet